Clinical Trials Logo
  1. Home
  2. Severe Eosinophilic Asthma
  3. NCT04084613

Mepolizumab: Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in Greece

Severe Eosinophilic Asthma Clinical Trial

Clinical Trial Summary

A prospective multi-centre, non-interventional observational study, that will be conducted in several centers in Greece for a 2-year time period (completion date December 2020), to describe patient characteristics, medical history, and the clinical benefit of mepolizumab in patients with severe eosinophilic asthma newly initiated to the drug.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04084613
Study type Observational
Source Attikon Hospital
Contact
Status Active, not recruiting
Phase
Start date January 2017
Completion date December 31, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed NCT02560610 - Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma Phase 2
Recruiting NCT06069310 - Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
Not yet recruiting NCT03652376 - Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic Asthma Phase 4
Recruiting NCT04542902 - Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma N/A
Completed NCT05180357 - RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.
Active, not recruiting NCT03833141 - Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.
Completed NCT05271526 - Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)
Not yet recruiting NCT06302959 - Clock Proteins as Prognostic Markers
Recruiting NCT05440656 - A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.
Completed NCT04159519 - A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab Phase 4
Completed NCT03907137 - Real World Study With Benralizumab in Severe Asthma in Switzerland
Completed NCT04126499 - Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain
Recruiting NCT03739320 - A Study on the Effect of Mepolizumab Therapy on Daily Physical Activity of Patients With Severe Eosinophilic Asthma